Article Information
- Received June 19, 2018
- Revision received October 31, 2018
- Accepted November 7, 2018
- Published online November 16, 2018.
Author Information
- Matthew J. Bellizzi1,2,3,
- Jennetta W. Hammond1,
- Herman Li1,
- Mary A. Gantz Marker4,
- Daniel F. Marker1,
- Robert S. Freeman4 and
- Harris A. Gelbard1,2,3,5
- 1Center for Neurotherapeutics Discovery, University of Rochester Medical Center, Rochester, NY 14642
- 2Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642
- 3Department of Neuroscience, University of Rochester Medical Center, Rochester, NY 14642
- 4Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642
- 5Departments of Pediatrics and Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642
- Correspondence should be addressed to Matthew J. Bellizzi, Department of Neurology (Neuroimmunology Division), 601 Elmwood Avenue, Box 605, Rochester, NY 14642, E-mail: matthew_bellizzi{at}urmc.rochester.edu.
Author contributions
Author contributions: M.J.B. and H.A.G. designed research; M.J.B., J.W.H., H.L., and M.A.G.M. performed research; M.J.B., J.W.H., M.A.G.M., D.F.M., and R.S.F. analyzed data; M.J.B. and H.A.G. wrote the paper.
Disclosures
URMC-099 is the proprietary asset of the University of Rochester Medical Center (US Patents: 8,846,909, 8,877,772, and 9,181,247, and international patents/applications to H.A.G.; References: PMCID: PMC3682381; PMC4032177). CLFB-1134 is the proprietary asset of Califia Bio, Inc. with US Patent 9,370,515 to V. S. Goodfellow and H.A.G. H.A.G. has no commercial interest in URMC-099 or CLFB-1134. All other authors declare no competing financial interests.
This work was supported by PO1 MH64570 (to H.A.G.), R44 NS092137 (to H.A.G.), TDFs from URMC (to H.A.G.) and by the National Multiple Sclerosis Society RG-1607-25423 (to M.J.B.).
Funding
National Multiple Sclerosis Society (National MS Society)
RG-1607-25423HHS | NIH | National Institute of Mental Health (NIMH)
PO1 MH64570HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
R44 NS092137
Other Version
- You are viewing the most recent version of this article.
- previous version (November 16, 2018).
Online Impact